Keyword: GSK

News

GSK Break-up “not Under Consideration”

17.05.2016 - A break-up of the UK’s largest pharmaceutical company, GlaxoSmithKline (GSK) is not under consideration at the moment, GSK Chairman Phillip Hampton told the company’s annual...

News

GSK to Waive Patents in Poor Countries

01.04.2016 - Glaxo SmithKline has announced it will waive patent protection for new medicines in the world’s poorest countries, such as Afghanistan, Rwanda and Cambodia, allowing cheaper...

News

Pfizer to Acquire Meningitis Vaccines From GSK

24.06.2015 - Pfizer has agreed to acquire the quadrivalent meningitis ACWY vaccines Nimenrix and Mencevax from GlaxoSmithKline (GSK) for €115 million. The deal, expected to close in the second...

News

GSK Acquires GlycoVaxyn for $212 Million

16.02.2015 - GlaxoSmithKline (GSK), the UK's largest drugmaker, has acquired Swiss-based GlycoVaxyn, a privately held specialist vaccine biopharmaceutical producer, from Edmond de Rothschild...

Markets & Companies

Accelerating the Benefits Achievable from Biocatalysis

02.10.2014 - Recently, Codexis has signed a platform technology license agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Codexis, a developer of biocatalysts for the...

News

China Fines GSK Nearly $500 Million on Bribery Charges

23.09.2014 - GlaxoSmithkline (GSK), the UK's largest pharmaceutical producer, will pay the Chinese government nearly $500 million in fines after being found guilty of offering bribes to...

News

GSK’s Ebola Vaccine Fast-tracked Into Clinical Trials

29.08.2014 - An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into clinical trials with human patients, and the company plans to immediately begin building a stockpile...

News

Gordon Sangster to Join Codexis as Senior Vice President & CFO

18.08.2014 - Codexis, a developer of biocatalysts for the pharmaceutical and fine chemical industries, announced that Gordon Sangster has agreed to join Codexis as Senior Vice President & Chief...